MIT Center for Integrative Synthetic Biology receives five-year NIH grant
Five-year grant will support research on cancer therapy, artificial tissue homeostasis, and infectious diseases.
Five-year grant will support research on cancer therapy, artificial tissue homeostasis, and infectious diseases.
MIT researchers find a way to boost lithium-air battery performance, with the help of modified viruses.
Particles that deliver vaccines directly to mucosal surfaces could defend against many infectious diseases.
New method for turning genes on and off could enable more complex synthetic biology circuits.
The state's education chief speaks with high-school science teachers on campus.
Establishing a neuroengineering community that can set new research directions and address emerging issues in brain science.
New findings could lead to drugs that fight back when tumors don’t respond to treatment.
Mehmet Fatih Yanik develops tools to answer some of the central questions in neuroscience.
MIT biologists reveal how cells control the direction in which the genome is read.
MIT studies of two influenza viruses reveal genetic mutations that could result in pandemic flu.
MIT professor honored for her innovations that take cues, and materials, from nature to tackle key societal issues.
Red blood cells, dengue fever and greenhouses have been on MIT senior Paula Trepman’s mind as she tackles problems in global health care.
Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
MIT study identifies influenza viruses circulating in pigs and birds that could pose a risk to humans.
New study measures physical changes in tumor cells as they become metastatic.